Kopran Limited Schedules Stakeholder Meetings for Merger Approval with Kopran Laboratories
Kopran Limited announces comprehensive stakeholder meetings scheduled for June 3, 2026, to consider and approve the proposed merger scheme with Kopran Laboratories Limited. The meetings follow an NCLT order dated April 9, 2026, and will involve six separate sessions for different stakeholder categories including equity shareholders, secured creditors, and unsecured creditors of both companies. The merger involves a scheme of amalgamation by absorption under the Companies Act, 2013, with proper regulatory compliance under SEBI regulations.
*this image is generated using AI for illustrative purposes only.
Kopran Limited has announced a series of stakeholder meetings scheduled for June 3, 2026, to consider and approve the proposed merger scheme with Kopran Laboratories Limited. The meetings are being convened pursuant to an order dated April 9, 2026, from the National Company Law Tribunal, Mumbai Bench.
Meeting Schedule and Structure
The company has organized six separate meetings for different stakeholder categories of both entities involved in the merger. All meetings will be conducted through video conferencing and other audio-visual means on Wednesday, June 3, 2026.
| Company: | Stakeholder Category: | Date: | Time (IST): |
|---|---|---|---|
| Kopran Limited | Equity Shareholders | June 3, 2026 | 10.00 a.m. |
| Kopran Limited | Secured Creditors | June 3, 2026 | 11.30 a.m. |
| Kopran Limited | Unsecured Creditors | June 3, 2026 | 1.00 p.m. |
| Kopran Laboratories Limited | Equity Shareholders | June 3, 2026 | 2.30 p.m. |
| Kopran Laboratories Limited | Secured Creditors | June 3, 2026 | 3.30 p.m. |
| Kopran Laboratories Limited | Unsecured Creditors | June 3, 2026 | 5.00 p.m. |
Merger Details
The proposed transaction involves a scheme of amalgamation through merger by absorption, where Kopran Laboratories Limited will serve as the transferor company and Kopran Limited as the transferee company. The scheme is being implemented under Sections 230 to 232 of the Companies Act, 2013, and other applicable provisions.
Communication and Documentation
The company announced on April 30, 2026, that notices are being dispatched electronically to shareholders and creditors whose email addresses are registered with the company, share transfer agent, or depository participant. Physical copies will be sent to those whose email addresses are not registered. Company Secretary and Compliance Officer Sunil Sodhani has signed the official communication to stock exchanges.
Regulatory Compliance
The announcement has been made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015. Complete meeting notices, explanatory statements, and annexures are available on the company's website at the dedicated amalgamation section. The communication has been formally submitted to both BSE Limited and The National Stock Exchange of India Limited.
The meetings represent a crucial step in the formal merger process, requiring approval from all stakeholder categories before the amalgamation can proceed under the regulatory framework.
Historical Stock Returns for Kopran
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.77% | +2.14% | +45.14% | -0.89% | -16.16% | -4.53% |
What synergies and cost savings does Kopran Limited expect to achieve from absorbing Kopran Laboratories Limited?
How will the merger impact Kopran Limited's market position in the pharmaceutical industry and its competitive landscape?
What is the proposed share exchange ratio for Kopran Laboratories shareholders in the merger transaction?
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
